PAUL SCHIMMEL - 22 Jul 2024 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
22 Jul 2024
Transactions value $
$184,613
Form type
4
Filing time
24 Jul 2024, 17:29:51 UTC
Previous filing
23 May 2024
Next filing
02 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATYR Common Stock Purchase $71.5K +41.1K +13.11% $1.74 354K 22 Jul 2024 See Footnote F1, F2
transaction ATYR Common Stock Purchase $12.1K +6.65K +1.88% $1.82 361K 23 Jul 2024 See Footnote F2, F3
transaction ATYR Common Stock Purchase $101K +52.3K +14.5% $1.93 413K 24 Jul 2024 See Footnote F2, F4
holding ATYR Common Stock 8.89K 22 Jul 2024 Direct
holding ATYR Common Stock 679K 22 Jul 2024 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.71 to $1.78 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 These shares are owned by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
F3 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.775 to $1.86 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F4 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.88 to $1.96 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F5 These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.